
Innate Pharma: Worth A Deeper Look (NASDAQ:IPHA)
Design Cells Topline Summary Innate Pharma (NASDAQ:IPHA) is a European biotech (XPAR:IPH) specializing in the development of immunotherapeutics for a variety of different cancer types. Their most advanced projects deal with engaging and activating natural […]